lobbying_activities: 1295878

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1295878	bb182dfd-9884-4d89-af3f-543242081c85	Q3	AGILENT TECHNOLOGIES, INC	54051	AGILENT TECHNOLOGIES INC	2012	third_quarter	CHM	S. 847, Safe Chemicals Act of 2011, Section 30. Reduction of Animal-Based Testing. H.R. 2521 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011, Title I, Research on Endocrine-Disrupting Chemicals S.1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011, Title I, Research on Endocrine-Disrupting Chemicals	Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE		9864	0	0	2012-10-08T16:10:09.687000-04:00